You can buy or sell XERS and other stocks, options, ETFs, and crypto commission-free!
Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol and XeriJect formulation technologies. Read More Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. The listed name for XERS is Xeris Pharmaceuticals, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 5, Pre-Market